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Introduction
AGel amyloidosis (AGel) is a neglected disease caused by deposition of gelsolin (GSN) amyloids and described for the first time in Finland in 1969 [1] . For a long time, AGel has been associated with the substitution of a single residue of the protein, D187 in the protein second domain (G2) (Figure 1 ), to either N or Y [2, 3] . It has also been considered an endemic pathology in Finland and named Familial Amyloidosis, Finnish-type (FAF). Nowadays, AGel is the preferred name for this disease [4] , as new cases have been gradually reported from many other countries demonstrating its worldwide occurrence.
In the last five years, the broader clinical use of genetic tests and the raised awareness of this class of diseases led to the identification of three new AGel forms. A new classification of the disease into three different types, according to the GSN sequence and the organ(s) involved in amyloid deposition, has been therefore proposed and includes: i) a systemic form, caused by D187N and D187Y mutations, respectively known as the Finnish-and Danish-variant; ii) a kidney localized form, associated with the deposition of GSN, either full-length or as fragments, carrying N184K or G167R mutation [5] [6] [7] ; and iii) a sporadic form, caused by wild-type (WT) GSN deposits surrounding a sellar glioma of the hypophysis [8] . All AGel types share the lack of effective pharmacological therapies that cure the disease targeting the source of toxicity, rather than acting only as palliative, symptomatic treatments.
Among the listed GSN variants, the D187N protein is the best biochemically and biophysically characterized. More than 20 years of in vitro and in vivo studies led to a consensus on the pathological mechanism underlying Finnish AGel type, although this model has been questioned by recent findings [9] . According to this model, aspartic acid 187 is part of a cluster of residues in the G2 domain of GSN, able to chelate a calcium ion [10] . Its N or Y substitution compromises calcium binding [11] [12] [13] [14] , leading to the exposure of an otherwise buried sequence, which is recognized by the furin protease [15] . In the Golgi, this intracellular enzyme cleaves GSN producing a C-terminal 68 kDa fragment (C68). C68 is later exported to the extracellular space where it is further processed by matrix metalloproteases, eventually producing 5 and 8 kDa highly amyloidogenic peptides [16] . These fragments rapidly aggregate and deposit in different tissues and organs [17, 18] . In stark contrast to the extensive biochemical knowledge available on the D187N mutant, its crystal structure has never been obtained, limiting the mechanistic understanding of GSN instability and aberrant proteolysis.
This study aims at characterizing the crystal structure of the isolated G2 domain (Figure 1 ) of the D187N protein (D187N G2 ) by exploiting a recently-developed nanobody (Nb) targeting GSN [19] . Different Nbs able to bind mutated GSN and to detect or prevent its aggregation, have been developed and tested [19] [20] [21] [22] . Among them, Nb11 proved to be the most efficient one. Studies performed in vitro and in vivo demonstrated that Nb11 binds G2 domain of GSN with high affinity, irrespective of calcium, and protects the mutated domain from furin proteolysis, thus skipping the first event of the aberrant proteolytic cascade (19) (20) (21) (22) . Inspired by the recent use of Nbs as an unique tool for structural biological studies [23] , we employed Nb11 to increase the stability of D187N G2 .
The successful co-crystallization of D187N G2 in complex with Nb11 (D187N G2 :Nb11) showed that the nanobody protects D187N G2 from furin-induced proteolysis, stabilizing the G2 C-terminal linker. Such stabilization is achieved allosterically since the Nb11 binding site locates far from the furin cleavage site. We complemented the structural results cross-referencing molecular dynamics (MD) simulations insights with thermal denaturation studies and furin proteolysis assays. These studies were extended to other mutations causing AGel, such as G167R and N184K.
In the absence of cellular or animal models recapitulating G167R and N184K-related AGel as well as the toxicity of the WT or mutated G2 domains, we decided to employ the invertebrate nematode Caenorhabditis elegans as "biosensor", able to recognize proteins which exert in vivo a biologically relevant effect [24] [25] [26] [27] . This approach takes advantage of the ability of the pharynx of worms, fundamental for their feeding and survival, to be inhibited when it meets molecules acting as chemical stressors [28] . This nematode-based method has been widely applied to recognize the toxicity of different amyloidogenic proteins in vivo, demonstrating that singular molecular mechanisms underlie their proteotoxic activity [24] [25] [26] [27] 29] . The protein folding, oligomerization propensity and the exposure of hydrophobic residues on the outside of the protein are relevant for the toxic action of β-amyloid (Aβ) and HIV-matrix protein p17 [25, 27, 29] . Instead, amyloidogenic cardiotoxic light chains are recognized as stressors by C. elegans thanks to their ability to interact with metal ions and continuously generate reactive oxygen species [24, 26] .
Our findings indicate that C. elegans efficiently recognizes the proteotoxic potential of the G2 domains and can discriminate between different level of toxicity. Furthermore, the stabilizing effects induced by Nb11 on G2 translated into an effective protection in vivo. These observations point to the use of this nematode-based model as a valuable tool for investigating the mechanisms underlying AGel. 
Materials and methods

Protein production
If not otherwise stated, all chemicals are from Sigma-Aldrich (Merck Millipore Ltd., Tullagreen, Carrigtwohill, Co. Cork, IRL) and of the best available purity. All preparative and analytic chromatographies were performed on a ÄKTA pure 25 system (GE Healthcare, Uppsala, Sweden) using prepacked columns from the same company.
Gelsolin expression and purification
Constructs and expression conditions for GSN variants as isolated G2 domain or full-length proteins were performed as already reported [30, 31] . The here named G2 refers to the shorter G2s construct in [30] and spans residues 151-266 of the GSN, according to the mature plasma isoform (Figure 1) . Purification followed the protocol previously described [30] . ΔG2 construct for the expression of WT ΔG2 harbours a WT sequence but lacks the first beta-strand (β1); it spans residues 168-266 and it is purified following the same protocol developed for the other G2 domains [31] . Briefly, G2 domains were passed through a Ni-chelating column (HisTrap) and gel filtered in a Superdex 75 following the removal of the His-tag. Full-length proteins went through three chromatographic steps without cleaving the N-terminal tag, HisTrap, MonoQ and gel filtration on a Superdex 200. G2 domains were stored in a 20 mM HEPES solution, pH 7.4, containing 100 mM NaCl and 1 mM CaCl 2 whereas full-length GSN in 20 mM HEPES solution, pH 7.4, containing 100 mM NaCl, 1 mM EDTA and 1 mM EGTA. Whenever required proteins were concentrated or buffer-exchanged in centrifugal filters Amicon ® Ultra (Merck Millipore Ltd., Tullagreen, Carrigtwohill, Co. Cork, IRL) with cutoffs of either 10k or 30k.
Nb11 expression and purification
The synthetic gene coding for Nb11 [19] fused to the thrombin cleavage site and 6xHis tag at the Cterminus was purchased by Eurofins genomics (Ebersberg, Germany). The sequence was optimized for E. coli codon usage and the gene cloned in a pET11 vector (Merck Millipore Ltd., Tullagreen, Carrigtwohill, Co. Cork, IRL). Tagged Nb11 was produced in SHuffle ® T7 E. coli cells (New England BioLabs Inc., Ipswich, USA) grown in LB medium. Once OD at 600 nm reached the value of 0.6, the expression of the gene was induced with 0.5 mM Isopropyl β-D-1-thiogalactopyranoside and cells harvested by centrifugation 16 h after incubation at 20 °C. Cells were resuspended in 20 mM Na 2 PO 4 , pH 7.4, containing 500 mM NaCl (supplemented with DNase I and cOmplete™ Protease Inhibitor Cocktail), lysed with a Basic Z Bench-top cell disruptor (Constant system Ltd., UK) operating at 25 kPsi and centrifuged at 38,000 RCF. The clarified crude extract was loaded on a 5 ml HisTrap and Nb11 eluted stepwise with the lysis buffer supplemented with 500 mM imidazole. Fractions enriched in Nb11 were passed through a Superdex 75, equilibrated with 20 mM HEPES, pH 7.4, 100 mM NaCl.
Crystallization, structure solution and analysis
Crystallization
D187N G2 :Nb11 complex for crystallization experiments was prepared by mixing equimolar amounts of the individual protein. The complex was loaded on a Superdex 75 increase (equilibrated with 20 mM HEPES, 100 mM NaCl, 1 mM CaCl 2 , pH 7.4), obtaining a single peak, consistent with the theoretical molecular weight of the complex, which was concentrated to 12 mg/ml in the same buffer. This sample was used for extensive crystallization screening using an Oryx-8 crystallization robot (Douglas Instruments Ltd, UK) and several commercial solutions in a sitting-drop set up. The purified complex (0.15/0.25 μl) was mixed with 0.25/0.15 μl of the reservoir solutions. Two different conditions yielded crystals after 2-6 days at 20 °C, namely (i) 0.1 M potassium thiocyanate, 30 % poly(ethylene glycol) methyl ether 2000 and 4.0 M sodium formate and (ii) 0.1 M potassium phosphate, pH 6.2, 10% (v/v) glycerol and 25% v/v 1,2 propanediol. Crystals were soaked with the respective reservoir solution supplemented with 20% glycerol, flash-frozen in liquid N 2 and diffraction data were collected at beamline ID23-1 (European Synchrotron Radiation Facility, Grenoble, France).
Data processing, structure solution, refinement and analysis
The two datasets (orthorhombic and tetragonal crystals grown in condition (i) and (ii), respectively) were processed with XDS [32] , scaled with Aimless [33] , and the structures solved by molecular replacement using the program phaser [34] and the PDB: 4S10 as the searching model. The orthorhombic structure (1.9 Å) was refined with phenix.refine [35] and manual model building was performed with COOT [36] . The final coordinates were deposited in the RCSB database with accession code PDB: 6H1F. The tetragonal structure (2.4 Å) could be refined only partially due to the poor quality of the diffraction (see Table 1 for the complete data collection and refinement statistics). The structural analysis was performed using the orthorhombic structure, except where indicated; all of the figures were prepared with either PyMOL or VMD [37, 38] .
All the other structures used for the B factor analysis were subjected to 3 cycles of refinement with phenix.refine. B factors for the WT G2 :Nb11 and D187N G2 :Nb11 were averaged between asymmetric molecules or between datasets, respectively. The rest of the analysis was performed as reported earlier [39] .
Molecular dynamics (MD) simulations
The crystal structure of G2 domain in complex with Nb11 (PDB: 4S10) was used to build the initial configuration for MD runs. The structure editing and building facilities provided by the HTMD software package [40] were used to construct a set of systems by selecting either the G2 domain only (chain D of the original PDB file) or the domain together with the bound Nb11 (chains D and B). In silico mutations were applied to restore residues 226 and 228 to their WT amino acids, to generate the D187N and N184K systems, and to remove the coordinated Ca 2+ ion where appropriate. The titratable side chains and initial H bond network were then optimized at pH 6.5 via the proteinPrepare procedure of HTMD [41] ; systems were solvated with transferable intermolecular potential with 3 points (TIP3P) water at 100 mM NaCl ionic strength and parameterized with the CHARMM36 force field [42] . The systems thus prepared were minimized and equilibrated for 4 ns in constant pressure conditions at 1 atm, yielding orthorhombic boxes with a water buffer of at least 15 Å per side. All simulations were conducted via the ACEMD software with a timestep of 4 fs, particle-mesh Ewalds long-range electrostatics treatment and the hydrogen mass repartitioning scheme [43] .
Each system was set for a production run in the number volume temperature (NVT) ensemble. Simulations of the G2 system without Nb11 were completely unrestrained and therefore the globular domain was free to diffuse in the solvent. To obtain a more efficient simulation box for the G2:Nb11 elongated complex while still preventing self-interactions with periodic images, its rotational diffusion was restricted by restraining Cα atoms of the Nb11"s secondary structure elements with a harmonic force of 0.025 kcal/mol/Å 2 . No restraint was applied to the G2 domain, nor to the contact region of Nb11. Runs were interrupted at 800 ns or when the full solvation of the C-terminus caused its extension outside of the simulation box. The WT G2 :Nb11 simulation was also truncated at 750 ns because the complex became transiently unbound. 
Thermal stability
Circular Dichroism (CD) spectroscopy
CD measurements were performed with a J-810 spectropolarimeter (JASCO Corp., Tokyo, Japan) equipped with a Peltier system for temperature control. All measurements were performed on 15 µM G2, Nb11, or the complex in 20 mM HEPES solution containing 100 mM NaCl and 1 mM CaCl 2 at pH 7.4. Temperature ramps were recorded from 10°C to 95°C (temperature slope 50 °C/h) in a 0.1 cm path length cuvette and monitored at 218 nm wavelength.
Thermofluor
Thermodynamic stabilities were also evaluated in the presence of Sypro Orange, a fluorogenic probe unspecifically binding hydrophobic surfaces and with excitation/emission spectra compatible with standard qPCR machines. WT and mutated G2 domains with or without equimolar Nb11, were diluted to 1 mg/ml in 20 mM HEPES solution containing 100 mM NaCl and 1 mM CaCl 2, pH 7.4. Each solution was mixed with 3 μl of a 1/500 (v/v) dilution of Sypro Orange , in a total volume of 20 µl. Fifteen µl of each sample were transferred to multiplate ® PCR Plates, sealed with Microseal ® "B" Film, and analysed in triplicate in an MJ Mini TM Thermal Cycler (hardware and consumables from Bio-Rad Laboratories Inc., Hercules, USA). The temperature was increased from 10 °C to 100 °C in 0.2 °C steps with 10 s equilibration before each measurement. Fluorescence intensity was measured within the excitation and emission wavelength ranges of 470-505 and 540-700 nm, respectively. T m was calculated as the minimum of the first-derivative of the traces using the manufacturer software and the value is reported as the average of triplicate measures.
Furin assay
Furin cleavage assays were performed in a total volume of 30 µl, using 1 U of commercial furin enzyme (New England BioLabs Inc., Ipswich, Massachusetts, USA) and 1 mg/ml of full-length WT and mutated GSN in 20 mM 2-(N-morpholino)ethanesulfonic acid, pH 6.5, containing 100 mM NaCl and 1 mM CaCl 2 in the presence or absence of 1 mg/ml of Nb11 (roughly 1:6 GSN:Nb11 molar ratio). To monitor the susceptibility to proteolysis, 12 μl aliquots of the reaction mix were collected right upon addition of furin and 3 h after incubation at 37 °C. The reaction was blocked by adding to each sample 4 µl of Sodium Dodecyl Sulphate (SDS) loading buffer 4X (BioIO-RadAD Laboratories Inc., Hercules, USA) supplemented with 0.7 M β-mercaptoethanol and by incubation at 90 °C for 3 min. Proteolysis reaction was monitored by SDS -PolyAcrylamide Gel Electrophoresis using ExpressPlus™ PAGE (12%) and the provided running buffer (GenScript Biotech Corp., USA ).
Proteotoxicity studies on C. elegans
Bristol N2 strain was obtained from the Caenorhabditis elegans Genetic Center (CGC, University of Minnesota, Minneapolis, MN, USA) and propagated at 20°C on solid Nematode Growth Medium (NGM) seeded with E. coli OP50 (CGC) for food. The effect of G2 domains on pharyngeal behavior was evaluated as already described [27] . Briefly, worms were incubated with 1-1000 μg/ml of G2 domains (100 worms/100 μl) in 2 mM HEPES solution containing 1 mM NaCl and 0.1 mM CaCl 2 , pH 7.4. Equimolar concentrations of WT G2 or WT ΔG2 (18 µM, corresponding to 250 μg/ml of WTG2) were administered to worms in the same conditions. Hydrogen peroxide (1 mM) was administered in dark conditions as a positive control. After 2 h of incubation on orbital shaking, worms were transferred onto NGM plates seeded with OP50 E. coli. The pharyngeal pumping rate, measured by counting the number of times the terminal bulb of the pharynx contracted over a 1-minute interval, was scored 2 and 24 h later. Control worms were fed 2 mM HEPES solution containing 1 mM NaCl and 0.1 mM CaCl 2 , pH 7.4 (Vehicle) only. To evaluate the protective effect of Nb11, worms were fed for 2 h G2 domains alone (250 µg/ml for WT G2 and D187N G2 and 100 µg/ml for N184K G2 and G167R G2, corresponding to 19 and 8 μM, respectively), 8-19 μM Nb11 alone, or G2 domains previously pre-incubated for 10 min at room temperature under shaking conditions with equimolar concentration of Nb11 to allow the formation of the complex. Nematodes were then transferred to NGM plates seeded with fresh OP50 E. coli and the pumping rate was scored after 2 and 24 h. Worms were also exposed to Vehicle in the same experimental conditions.
Results
Crystal structure of the D187N G2 :Nb11 complex
Crystals of the isolated D187N G2 :Nb11 complex readily appeared in different conditions, allowing the collection of two X-ray diffraction datasets of different quality. Particularly, the crystal grown in condition (i) above, belonging to the P2 1 2 1 2 1 space group, diffracted to 1.9 Å resolution, and the one that appeared in condition (ii), belonging to the P4 1 2 1 2 space group, diffracted to 2.4 Å. The resulting models are hereafter referred to as the orthorhombic and tetragonal structure, respectively ( Figure 2) ; the complete list of the data collection and refinement statistics is reported in Table 1 . Due to the difference in quality of the data, the orthorhombic structure is used to infer the impact of the D187N mutation on the GSN structure (Figure 2) , unless otherwise stated.
Orthorhombic
Tetragonal PDB ID 6H1F - Both the structures obtained confirm that Nb11 binds the G2 domain over an extended area including the β5-loop-α2 region (residues 230-234, 238-245) and the loop-β4 stretch (residues 193-198) as already observed for WT gelsolin (PDB: 4S10, [19] ). The binding region is opposite from the aberrant cleavage site (residues 168-172), which had previously raised suspicions of a crystallographic artifact. The structures obtained here rule out this hypothesis, since it is unlikely that three different crystal packings (WT G2 :Nb11 belongs to P1 space group) artificially stabilize the same assembly (Figure 2A) . Thus, the 3D structures of G2:Nb11 appear unable to explain how the binding to Nb11 in a distal area could shield G2 from furin proteolysis without additional data.
Data collection
The second remarkable feature of the WT G2 and D187N G2 assemblies is that the G2 structures are almost identical (root mean squared deviation, RMSD, 0.25 Å over 90 Cα atoms). Besides, two striking differences were observed: the absence of the coordinated calcium ion, and a shorter stretch of ordered C-terminal segment in D187N G2 (Figure 2A ). In the C-terminus of mutated G2, we could only model up to residue 258 and 255 in the orthorhombic and tetragonal structure, respectively (Figure 2A ), suggesting that the remaining stretch of the protein is highly flexible and invisible to X-rays (the last resolved amino acid in WT G2 is 261). The disorder prediction algorithm MobiDBlite [44] indeed reports a putative disordered region around residues 220-258 owing to its polyampholitic character (Supplementary Figure S1) . Besides the C-terminus, all residues are modelled but a few side chains of the Nb11 chain (namely V2, K65 and L128).
The superimposition of the orthorhombic structure of D187N G2 to that of the WT G2 (PDB: 1KCQ), shows no major conformational changes (as is the case for the G167R variant) nor the rearrangement of the hydrogen bond network in the core of the domain in the N184K variant, unlike it was observed for the other G2 mutants ( Figure 2B ). Residues G186, D187 and E209 of the calcium-coordinating cluster show remarkable conformational conservation (D259, the fourth residue of the cluster, lies in the unresolved C-terminal stretch). 
Impact of the D187N mutation on the structure of the G2 domain
A large body of evidence indicates that the presence of D187N mutation mainly affects the ability to bind the calcium ion [11] [12] [13] [14] . In WT G2 the calcium binding site is a highly polar cavity delimited by the protein core, the side chain of K166 and the C-terminal tail ( Figure 3A , left). The ion is pentacoordinated by the side-chains of residue D187, E209 and D259 and by the main-chain O atom of G186. The site is open to the solvent on the side opposite to K166, where two ordered water molecules are visible in the WT G2 structure ( Figure 3A , left).
In the orthorhombic structure of D187N G2 , although the overall geometry of the calcium binding is maintained, some differences are visible. The residue D259 could not be modeled and the presence of a water molecule in its place (bound to the O atom of T257) shows that the residue is extruded from the cavity. Two more water molecules are found overlapping neither with the calcium ion nor with other solvent molecules present in the WT G2 structure. The side-chain of K166 also undergoes small rearrangements: its amino tip becomes more flexible, based on the quality of the electron density, and the interaction with residues 187 and 259 is either lost or weakened. The N187-K166 distance is 4.6 Å, whereas 3.1 Å separate D187 from K166 in the WT G2 due to a stronger polar interaction ( Figure 3A , middle). This small reorganization of the calcium binding residues, as well as the lack of the coordinated ion, are sufficient to create a small cavity ( Figure 3A , right, computed by PyMOL [37] ), a known source of instability in proteins [45] . Even though this cleft is solventexposed and accessible, the high concentration of its acidic residues might be the force driving the stretching of both D259 residue and the whole C-terminal tail.
The same cavity is fully open in the tetragonal structure of D187N G2 , where we were able to model only up to residue 255. The electron density for the calcium site is of poor quality (data not shown), the side-chain of K166 is barely visible and no solvent molecule could be modelled. The orthorhombic and tetragonal structures seem to represent two intermediate states toward the domain"s (partial) unfolding. 
Nb11 binding modulates C-terminal disorder allosterically
Based on our structures, one can hypothesize that Nb11 binding induces D187N G2 in a proteolysisresistant conformation, but crystallographic analysis alone is not sufficient to assess whether the flexibility of the D187N G2 C-terminal tail and exposure of the calcium cavity lead to its susceptibility to furin proteolysis. To investigate the impact of the mutation on local kinetics or a possible conformational selection effect by Nb11 binding, we analyzed the domain's dynamics via MD simulations. We simulated the WT G2 and D187N G2 systems in the presence or absence of bound Nb11 (Table 2) , starting from the crystallographic poses reported in PDB: 4S10 (see Methods section). The most striking result was the fast opening and solvent-exposure of the C-terminus segment, which occurred within the first hundred nanoseconds, in all of the structures of D187N G2 lacking the Ca 2+ ion (Table 2 ). In the crystallographic structures of the WT G2 protein, the C-terminal region up until residue 259 lies near the β1-β2 hinge loop which hosts the furin cleavage site (R 169 -V-V-R 172 ), indicating a possible steric protection mechanism already suggested by Huff et al. [14] . In consistency with our crystallographic results, MD did not uncover further major "static" structural rearrangements between the WT G2 , D187N G2 and D187N G2 :Nb11 in the timescales tested.
Sample
Local (residue-wise) fluctuations across the G2 residues ( Figure 4A , red curve) indicate two major areas of destabilization in the D187N G2 with respect to the WT G2 , namely (a) the region 179-183 (helix α0) is located; and (b) the arm of the domain, i.e. the C-terminal region up to residue 240 including the β5-α2 loop, the α2 helix and the opening C-terminal arm plus its elbow at helix α2. Binding of Nb11 to the D187N G2 ( Figure 4A , cyan curve) almost entirely abolished the fluctuations in both regions. In other words, Nb11 essentially restores the fluctuation dynamics of the mutant to the low level present in the WT G2 . The simulation of the WT G2 :Nb11 complex confirmed that the Nb11 does not significantly alter the local stability of the WT G2 , although it partially stabilizes the β5-α2 region where it binds. 
Overview of the main molecular features and conformational diversity observed during the simulations of D187N G2 in the presence or absence of Nb11 (light grey). Dark grey: snapshots of the disordered C-terminus from the conformational ensemble.
The main molecular events underlying the destabilization induced by the D187N mutation are summarized in Figure 4C . In the absence of Nb11, the fluctuations in D187N G2 lead to the already described flexibility of the C-terminal tail with the increase of its entropy. Then the transient displacement of the α2 helix occurs, followed by the disruption of the hydrophobic core triad composed by W180, F183 and W200 residues (Supplementary Figure S2) . Noteworthy, the ConSurf algorithm indicates that F183, belonging to the α0 helix, is strongly conserved in gelsolinlike domains (see Discussion) [46] . Even though binding of Nb11 has only a minor impact on the resolved pose of the C-terminal tail, its conformational entropy was reduced compared with D187N G2 alone, thus likely preventing the rearrangement of the α2 helix and the exposure of the core residues.
To validate the computational findings, we further compared the amount of disorder obtained from the simulations with the crystallographic data. Although not ideal to investigate protein dynamics, crystallographic data in the 2 Å resolution range does contain information on the disorder and mobility of the single atoms in the crystal [47] . To this purpose, B factors shown in Figure 4B were extracted from the structures of D187N G2 :Nb11, WT G2 (PDB: 1KCQ) and WT G2 :Nb11 (PDB: 4S10) (the structure of the D187N G2 variant alone is unavailable). B values were averaged between datasets or symmetric molecules (where available) and normalized to zero mean and unit variance in order to obtain a B z-score comparable between models ( Figure 4B ). As expected, we observe a sharp decrease of WT G2 and D187N G2 B z-score at the Nb11 binding interface, indicating that this region becomes less dynamic. Stabilization also propagates through the C-terminus and the α2 helix (that is partly involved in the interaction with Nb). The hinge loop formed by amino acid residues 167-170, which hosts the sequence recognized by furin, results very dynamic in both WT G2 and D187N G2 structures (with and without Nb11) suggesting that the presence of the mutation does not directly affect the conformation or the stability of this loop.
The MD analysis identified two instability hotspots in the mutated G2 domain: the α0 helix and the stretch comprising β5-α2 loop and α2 helix. In the first region we were not able to detect any significant differences between the structure of the WT G2 and that of D187N G2 stabilized by Nb11 (data not shown). As shown in Figure 3B (left panel), the WT G2 β5-α2 loop is connected to the Cterminal tail and the calcium binding site through a solvent-mediated H-bond network. The structure of the mutant reveals a reorganization of the polar contacts mostly due to a drift of the backbone in the 235-239 stretch and the different conformation of side-chains of residues 185 and 236 ( Figure 3B , right panel). Overall, these observations indicate that the D187N substitution causes a slight loss in connectivity of the G2 domain essentially due to the loss of the coordinated Ca 2+ . Major rearrangements observed in the simulations are thus likely prevented by the binding to Nb11, which partly compensates for the loss of the calcium ion and forces the first half of the C terminus of D187N in a WT-like conformation.
Nb11 protects all pathogenic GSN variants from aberrant furin proteolysis
The ability of Nb11 to bind D187N-mutated GSN and to inhibit its proteolysis by furin has been extensively demonstrated in vitro and in vivo [19] . Recently, we have characterized two novel GSN pathogenic variants reported as responsible for a renal localized amyloidosis, G167R and N184K [30, 31] . Structural and functional analyses revealed that the N184K substitution induces a reorganization of the connection in the core of the G2 domain; contrarily, G167R mutation promotes the dimerization of the protein by a domain swap mechanism. Similarly to D187N, both substitutions impair protein stability and ultimately lead to protein degradation and aggregation. Therefore, we wondered if Nb11 would also be able to bind the variants responsible for the renal disease and protect these proteins against furin proteolysis. The susceptibility to furin proteolysis of full-length WT and the three aforementioned mutants was tested in the presence or the absence of a 6-fold molar excess of Nb11.
Full-length activated (i.e. calcium-bound) GSN is a flexible protein prone to unspecific proteolysis, a phenomenon that is more evident for the mutants ( Figure 5 , band marked with *). Its susceptibility to furin cleavage was therefore tested over a short incubation time (3 h) at 37 °C. Furin activity produces two fragments, the well-known C68 and one here named N17, which is visible only when proteolysis proceed to a larger extent, as is the case for the G167R variant. Nb11 dramatically reduced the susceptibility to furin of all the tested variants, either abolishing any trace of its activity, or significantly slowing down the process. 
Nb11 stabilizes the mutated G2 fold
The protection exerted by Nb11 on the furin proteolysis cannot be simply explained by steric hindrance. Moreover, our structural and computational analyses pointed at a stability modulation effect. To further elucidate the molecular mechanism underlying the action of the nanobody, we assayed Nb11"s impact on the thermal stability of the G2 variants. Denaturation of the proteins was induced by a linear temperature gradient (from 20°C up to 90°C) and studied by CD spectroscopy at 218 nm (sensitive to α-helical content) in the presence of saturating calcium concentration. WT G2 and all the mutated domains showed a sigmoidal increase in ellipticity upon unfolding (Supplementary Figure S3) . Contrarily, Nb11 signal decreased over time as the immunoglobulinlike domain lacks α-helical content. Interpretation of the melting curves of the complexes is therefore hindered by the opposing behavior of the two proteins.
To analyze CD data, we compared the denaturation curve obtained for the G2:Nb11 complex with the arithmetical sum of the experiments performed on the individual subunits of the complex. We hypothesize that, in the case there is no stabilization, the curve of the complex should roughly superimpose to the curve of the sum, because the G2 domain and Nb11 unfold independently. Indeed, this was the behavior observed for the WT G2 , in which the binding to Nb11 seems not to have any impact on the protein stability ( Figure 6A ). In contrast, all the pathological G2 mutants showed significant differences between the denaturation profile of the sum and that of the experimental complex ( Figure 6A ). Figure 6B . Reported values are the average of three independent measurements ± SD, at most. T m for Nb11 alone in the same experimental conditions is 50 ± 1 °C.
WT
To quantify the stabilizing effect of Nb11, we performed thermofluor experiments of the G2 domains, whose denaturation is achieved in the presence of a fluorogenic probe ( Figure 6B ). As reported in Table 3 , the T m values for the mutated G2 domains were lower than that of the WT G2 with differences between the T m value of WT G2 and that of the mutated proteins (ΔT m ) ranging from 12.6°C to 17.3°C. These results are similar to those previously reported, measured by CD (see supplementary Table 1 ) [10, 14, 30, 31] . The WT G2 :Nb11 complex unfolds at a lower temperature than the WT G2 alone, suggesting the absence of any stabilization induced by Nb11. On the contrary, mutants" thermal stability significantly benefits from Nb11 binding as indicated by the ΔT m values which dropped to 3.1-4.7 °C (Table 3 ).
In agreement with the structural observations, these data show that Nb11 protects G2 from aberrant proteolysis reverting the destabilization induced by the mutations. It is noteworthy that both T m experimental approaches are insensible to the displacement of the C-terminal tail, because it neither results in a loss of secondary structures nor it leads to the exposure of hydrophobic patches, being the calcium pocket very polar. 
Nb11 counteracts the proteotoxicity of G2 domains in C. elegans
It is well known that the administration to nematodes of a toxic compound, such as a misfolded protein, induces a pharyngeal dysfunction [24, 25, 28, 29] that can be evaluated by counting the number of worm"s pharyngeal contractions, defined as "pumping rate" [28] . Therefore, we employed C. elegans assays to determine whether the structural changes and the stabilizing effects induced by Nb11 on the mutated G2 variants can also affect their biological properties.
First, we evaluated the ability of WT G2 or mutated G2 to induce a pharyngeal dysfunction in worms. To this end, 250 µg/ml of each protein was administered to worms, and the pharyngeal contraction was determined at different times after the treatment. After 2 h the pumping rate of WT G2 -fed worms is significantly reduced compared to those fed vehicle (228.4 ± 1.7 and 217.1 ± 1.6 pumps/min for vehicle-and WT G2 -fed worms, respectively) ( Figure 7A ). A greater inhibition was observed in nematodes treated with mutated G2 domains, particularly N184K G2 (177.9 ± 1.8 pumps/min) which is significantly more toxic than G167R G2 and D187N G2 variants (191.6 ± 2.3 and 208.4 ± 3.0 pumps/min, respectively) ( Figure 7A ). These outcomes were comparable to those of worms treated with 10 mM hydrogen peroxide, used as positive stress control (183.7 ± 1.6 pumps/min, p<0.0001 vs vehicle, Student"s t-test), indicating that the reduction of pharyngeal contraction induced by the mutated G2 domains is biologically relevant.
We also observe that the pharyngeal impairment induced by WT G2 is transient because the pumping rate scored 24 h after the administration was similar to that of vehicle-fed nematodes (233.4 ± 2.3 and 225.8 ± 1.7 pumps/min for vehicle and WT G2 , respectively). On the contrary, the mutated G2 domains induced a persistent pharyngeal functional damage, without complete recovery even after 24 h ( Figure 7B ). Whereas the pharyngeal dysfunction induced by D187N G2 did not change over time (208.4 ± 3.8 and 211.3 ± 3.5 pumps/min at 2 and 24 h, respectively), those caused by G167R G2 and N184K G2 significantly decreased (Supplementary Figure 4) .
Trying to establish a relationship between protein toxicity and folding, worms were fed with equimolar concentration of either WT G2 or WT ΔG2 . Lacking the β1 strand, WT ΔG2 is unable to properly fold and displays spectroscopy characteristics typical of a natively unfolded protein under physiological conditions [31] . We observed that the unfolded G2 domain (WT ΔG2 ) was significantly more effective in reducing the pharyngeal pumping than the folded one underlining the relevance of the folding status for the toxicity (Supplementary Figure 5) .
The different toxic potential of the mutated G2 domains is further proven by the experiments evaluating their dose-dependent effects on the pharynx of worms ( Figure 7C-D) . IC 50 (half-maximal effect) values calculated 2h after the exposure resulted significantly higher for WT G2 than for mutated G2 and, among these, the higher toxicity was obtained for N184K G2 (Table 4) . Similar IC 50 values are calculated after 24 h for G167R G2 and D187N G2 whereas a 4-fold increase is observed for N184K G2 (Table 4 ).
These findings indicate that C. elegans can efficiently recognize the proteotoxic potential of G2 domains, pointing to its use as a rapid and valuable tool to investigate the mechanisms underlying AGel. Also, the different proteotoxic abilities exerted by the various mutated G2 domains suggests that each mutation may drive a specific damage.
The effect of Nb11 on the pharyngeal toxicity induced by the G2 domains was then investigated. For these experiments, worms were fed 250 µg/ml of WT G2 or D187N G2 (corresponding to 19 µM), 100 µg/ml of N184K G2 or G167R G2 (corresponding to 8 µM), concentrations close to the IC 50 value calculated for the 2h of exposure (Table 3) . G2s were administered alone or as complexes with an equimolar concentration of Nb11. Although Nb11 alone caused a significant reduction of the pharyngeal function, both its toxicity as well as those of G2 domains scored 2 h after administration were neutralized when co-administered ( Figure 7E) . Noteworthy, the effect of Nb11 on the toxicity induced by the mutated G2 domains were still present 24 h after the treatment (Supplementary Figure 6) as an indication of sustained protective action.
These data indicate that the structural and molecular effects induced by Nb11 on the G2 variants can translate into a biologically relevant effect in vivo. Nb11 can bind and chaperone the D187N G2 as well as the G2 domains of the renal variants counteracting their proteotoxic potential. 
Discussion
The current model of the pathological mechanism underlying AGel amyloidosis is mostly based on studies performed on the D187N-mutated protein and experiments conducted in vitro and in vivo on transgenic animals expressing this variant [15, 16, 48] . Results obtained with D187N likely also apply to the later discovered Danish variant (D187Y), although some differences were reported [49] . On the contrary, the mechanism underlying the recently discovered renal disease associated with the N184K and G167R mutations have not been fully elucidated. Interestingly, while the crystallographic structures of isolated G2 domains carrying the N184K or G167R mutation are already available [30, 31] , until now the D187N/Y structural characterization had not been elucidated.
We here demonstrated that crystallization of the D187N G2 domain was possible only in complex with a previously developed nanobody, called Nb11 [19] . Nb11 tightly binds to gelsolin and protects the D187N variant from aberrant furin proteolysis. In the analysis of the crystal structure, we must consider that the binding of Nb11 somehow biases our model. Indeed, we are observing a proteolysis-resistant species that lost, to some extent, the structural determinants of its proteotoxicity.
To elucidate the mechanism of protection exerted by Nb11 it is necessary to understand the pathological mechanism of D187N mutation (and vice versa). Clearly, Nb11 acts as a protective chaperone; however, the molecular mechanism behind such function was as yet unclear, mainly because Nb11 binds G2 in a position distant from the furin cleavage site (Figure 2 ). Regarding the D187N mutation, a large body of literature is already available, and these studies converged to a general agreement, i.e. that the D187N substitution disrupts calcium binding in G2 and the thermodynamic stability of the mutant is decreased to levels similar to those of the WT protein deprived of calcium [10] [11] [12] 49] . Ultimately the mutation leads to the exposure of an otherwise buried sequence, which is aberrantly cleaved by furin. However, the correlation between calcium binding impairment and susceptibility to proteolysis has been the object of discussion. One hypothesis is that the mutation somehow induces a conformational change of the native state that leads to the exposure of the furin site. Another possibility is that the loss of coordinated calcium increases the population of (partially) unfolded protein, which is generally prone to proteolysis [10] [11] [12] 49] . The partial disorder hypothesis is consistent with the crystallographic structures, the thermodynamic data as well as with the MD results, which in the absence of the coordinated cation show a fast (on a timescale of tens of ns) opening of the C-terminal stretch. Calcium-mediated disorder-to-order induction has been shown, e.g. in sortase [50, 51] , adenylate cyclase toxin [52] , and possibly several others [53, 54] .
Interestingly, Kazmirsky and coworkers came to a similar conclusion through a detailed NMR analysis of the D187N variant [12] . In the study, they suggested that the C-terminal tail of the pathogenic variant might be less structured compared to the WT. It might be tempting to explain the increased susceptibility to proteolysis solely based on the flexibility of the C-terminus, which indeed interacts with the hinge loop and exerts some steric protection. However, even the crystallographic structures of the D187N G2 :Nb11 complex reveal a destabilized tail, and the simulations show a similar dynamic behavior of the stretch irrespective of Nb11 binding. Destabilization of the C-terminus might likely be a necessary condition, but it seems not to be sufficient for the efficient proteolytic cleavage.
In conclusion, we believe that the destabilization of the C-terminal tail is the direct consequence of the loss of the Ca 2+ ion induced by D187N mutation. Such increased flexibility is the first event that triggers the sequential opening of the gelsolin fold, which results in the exposure of residues of the hydrophobic core. The process is likely reversible and this partially unfolded state of the protein is susceptible to furin proteolysis. In the complex with Nb11, the binding interface, including α0 and α2-loop-β5, becomes more rigidly anchored to the proper WT conformation. The latter Nb11-stabilized region lies at the base of the disorder-prone C terminus, forming an elbow of sorts. We speculate that Nb11 stabilization reverses, at least in part, the entropy gain due to the abolished coordination of Ca 2+ .
Even though Nb11 was raised against WT gelsolin, it was shown to bind the D187N variant as well, with a slightly lower affinity [19] . Crystallographic structures of N184K and G167R variants, as isolated G2 as well, are also available [30, 31] . N184K neither impairs calcium binding nor it significantly destabilizes the C-terminal tail. Loss of conformational stability of N184K-mutated G2 comes from the rearrangement of the polar contacts, which the mutated residue is part of, in the core of the domain. As for the D187N/Y case, N184K mutation eventually leads to furin proteolysis. Contrarily, the pathological mechanism underlying the G167R-dependent disease is still to be fully elucidated. An alternative amyloidogenic pathway has in fact been proposed based on the observation that this variant dimerizes via a domain-swap mechanism [31] . At the same time, even the G167R mutant is prone to aberrant proteolysis and shows impaired thermal stability.
The WT G2 and D187N-and N184K-mutated variants share a high structural conservation. The Nb11 binding interface of the G167R G2 variant is not affected by its dimerization. As a consequence, it comes as no surprise that Nb11 binds the renal variants with similar efficiency. On the contrary, the protection from proteolysis of the N184K and G167R mutants would have been difficult to predict because the impact of these substitutions on the G2 dynamics as well as the mechanism of destabilization is significantly different.
We tested Nb11 protection of the renal variants in standard furin assays and observed indirect inhibition of the protease activity comparable to that of the D187N variant. To further investigate this aspect, we aimed at testing Nb11"s activity on mutated G2 in a more biological context. As neither an animal nor a cell model of renal AGel amyloidosis is currently available, we employed a nematode-based assay already developed and validated by our group and already successfully used to determine the toxicity of different amyloidogenic proteins and investigate the mechanisms underlying their proteotoxic effect [24] [25] [26] [27] 29] . This is based on the knowledge that the rhythmic contraction and relaxation of the C. elegans pharynx, the organ fundamental for the worm"s feeding and survival, is sensitive to molecules that can act as "chemical stressors" such as some proteins induced in stress conditions. We here showed for the first time that all isolated G2, at concentrations similar to those observed as circulating in humans [55] can cause a biologically relevant toxic effect recognized by C. elegans. Whereas WT G2 only induced a transient reduction of the pharyngeal pumping, all the pathological mutants caused an impairment which persisted still after 24 hours, suggesting that these proteins caused a permanent tissue damage.
Interestingly, Nb11, which was able to bind and chaperone all the disease-causing mutant forms of GSN and prevent their aberrant proteolysis, completely abolished the proteotoxic effects induced by G2 domains in worms. Although the mechanisms underlying the ability of C. elegans to recognize G2 domain as toxic remains to be elucidated, these findings are consistent with the hypothesis that the toxicity can be ascribed to the partially unfolded status of the proteins and that Nb11 hides the structural determinant of toxicity. The involvement of the folding status in G2 toxicity was further assessed by using a protein totally unfolded due to the truncation of residues 151-167. The toxic effect caused by WT ΔG2 protein on the pharynx of worms was greater and more persistent than that observed with the folded WT G2 . Additional studies are required to fully elucidate the mechanisms underlying the toxicity of G2 domains on the C. elegans pharynx.
The knowledge of high-resolution determinants of D187N toxicity and the therapeutic action of Nb11 may contribute to the ongoing efforts in the expansion of the currently limited landscape of therapeutic interventions against FAF and other amyloidosis-related diseases. The use of the C. elegans-based assay for the evaluation of the proteotoxic potential of the G2 domains offers unprecedented opportunities to investigate the molecular mechanisms underlying the AGel forms caused by different GSN variants. This model can also be employed for rapidly screen the protective effect of novel or repurposed drugs thus accelerating the identification of an effective therapy against AGel amyloidosis.
Conclusions
Nb11 works as a pharmacological chaperone (sometimes referred to as pharmacoperone), a concept originally formulated in the context of small chemicals, rather than macromolecules. Such chaperones restore mutated proteins' function or prevent misfolding, either stabilizing the native fold, or assisting the folding process. Although the pharmacoperone concept has been around for a while, only a limited number of successful examples can be found in literature [56] [57] [58] , and very few drugs belonging to this family are available on the market. Nb11 is, in our knowledge, the first case of a pharmacoperone-like nanobody whose efficacy has been proven in vivo. Contrary to other previously developed pharmacological chaperones, which are mutation-specific, Nb11 protects all gelsolin pathological variants identified so far, irrespective of the different pathways or mechanisms leading to their degradation and/or aggregation. Furthermore, disease-causing mutations yield proteins which are at times difficult to express and purify, due to their solubility, instability or toxicity. Our data show that pharmacological chaperones can be developed using the WT protein as a target, aiming at the stabilization of the native-like conformation, thus increasing the number of diseases that can be potentially tackled with an analogous strategy. Wide-spectrum applicability is of pivotal importance in view of the potential application of Nbs in therapy.
